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Abstract:
Tumor necrosis factor (TNF) receptor associated factor 2 (Traf2) is suspected to
be involved in the anti-apoptotic pathways of the innate immune system in the zebrafish.
The expression of three different forms of Traf2, 2a1, 2a2, and 2b, was knocked down in
pairs using antisense morpholino oligonucleotides in zebrafish embryos. A rescue was
attempted by knocking down a potential receptor for the Traf2 to pathway. After
infection with snakehead rhabdovirus (SHRV), mortality was quantified and the
apoptotic effects of each of the Traf2 genes was assessed. Cell death was quantified using
the TUNEL technique. The findings indicated that at least two zebrafish Traf2 proteins
were necessary for function. Increased mortality due to infection was not caused by an
increased amount of virus in the Traf2 morphants or increased amount of apoptosis.
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Introduction
We are inundated every day by viruses. Ranging from the common cold to
sexually transmitted diseases, everyone may be impacted by a viral infection at some
point in their lives. The general viral infection process occurs when the virus is
endocytosed by the cell. Once the virus enters, the nucleic acid of the virus is released
into the cell cytoplasm to utilize host cell proteins for replication. As a protective
mechanism, host cell proteins such as Toll-like receptors, recognize the DNA or RNA of
the virus as foreign to the host. This initiates a protein signaling cascade that ultimately
results in the translocation of transcription factors into the nucleus to transcribe proinflammatory cytokines. Production of pro-inflammatory cytokines is the cell’s way of
defending against the viral infection.
The immune system is the body’s defense against pathogens of all kinds, like
viruses. There are two major branches: the innate immune system and the adaptive
immune system. The adaptive immune system takes up to ten days to develop an
appropriate response, but is then more specific to the pathogen and has a memory of the
pathogen. It is composed of specialized white blood cells known as B and T-cells. The
innate immune system protects the body during those first seven to ten days. Without a
vigorous innate immune response, the adaptive immune response will not be as strong.
The innate immune system provides a general response and is composed of the skin,
mucous membranes, and various phagocytic cells. Generalized cell receptors, known as
Toll-like receptors (TLRs), are responsible for recognizing the invading pathogens and
initiating protein cascades to help cells deal with the infection. TLRs 3, 7, 8, and 9 are
involved in viral recognition.
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In mammalian systems, TLR3 uses a TICAM1 dependent pathway to initiate the
protein cascades, while TLRs 7-9 use a MyD88 dependent pathway. Zebrafish do not
possess a protein homolog to TICAM1, and thus can only use MyD88-dependent
signaling through the TLRs. To find potential signaling partners for MyD88 in zebrafish,
a pulldown assay was conducted using zebrafish MyD88 as bait (unpublished data from
Charette et al). A potential signaling partner for MyD88 was found to be Traf2 in this
pulldown.
One of the adaptor proteins in the mammalian TLR3-TICAM1 dependent pathway in
mammalian systems is Traf2, a member of the tumor necrosis factor receptor associated
factor protein family. In mammalian systems, Traf2 does not associate with MyD88, but
based on the previous findings in the Kim lab, we hypothesized that Traf2 may be
associating with MyD88 in a unique interaction not seen in mammalian systems. If Traf2
is interacting with MyD88 in zebrafish signaling pathways this would be a unique and
novel interaction not seen in any mammalian systems. For my senior thesis project, I
examined the potential role of Traf2 in the zebrafish immune system.
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Literature Review
Zebrafish as a model organism
During the 1960s, Dr. George Streisinger developed a new model organism for
studying human diseases: the zebrafish (35). Over the next half century, this new model
organism exploded with possibilities for research. A quick summary of some of these
major landmarks is summarized in Figure 1 (adapted from 18). These early years were

Figure 1: Major developments in zebrafish research (18).
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focused on genes and genetics, especially since transcription and translation mechanisms
were just being deduced. Streisinger was at the forefront of the genetics work with
phages, an interest that naturally led him to mutational analysis in vertebrates (18).
Additionally, Steisinger was known as a fish hobbyist. Trials with a variety of tropical
fishes left zebrafish as the prime candidate over other fish such as the medaka – with
previously developed genetic experimentation – due to their prodigious breeding,
external fertilization, and clear embryos (18). His work during the 70s and 80s produced
haploid embryos and homozygous diploid clones, throwing zebrafish into the limelight
(35).
The zebrafish (Danio rerio) is a common aquarium fish and excellent model
organism for molecular research. The externally fertilized embryos develop in optically
clear shells. The large clutch size and short generation time allow larger studies than
more conventional model organisms such as mice (8, 14). Embryogenesis is completed
by 50 hours post fertilization (hpf). Four days post fertilization (dpf) the adaptive immune
system begins developing and is fully functional four to six weeks after fertilization (8,
46). The zebrafish genome is completely sequenced and many molecular tools such as
morpholinos are readily available to manipulate the genome. Other molecular tools
include zinc finger nucleases, highly homozygous strains of zebrafish, and transgenic fish
(14, 46).
Zebrafish are excellent models for studying the immune system, particularly
innate immunity (35). A variety of pathogens and even some parasitic organisms such as
dinoflagellates have been used to replicate infections in human systems and set zebrafish
as a model for infectious disease (Table 1) (35, 55).

5
Table 1: Pathogens infecting zebrafish to model infectious diseases (35).
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Snakehead Rhabdovirus
Snakehead rhabdovirus (SHRV) is in the virus family Rhabdoviridae. It is
enveloped and contains a negative-sense RNA genome. Originally cultured from infected
snakehead fish, SHRV is effective in inducing viral infections and in zebrafish induces a
cytokine response (35, 40). SHRV replicates at temperatures between 24 and 30 oC, an
ideal temperature since zebrafish are maintained at 28 oC. Phelan et al demonstrated an
effective infection technique for embryos and adult fish alike using immersion in egg
water and virus (40). Immersing embryos from 24 hours post fertilization (hpf) to 3 days
post fertilization (dpf) in 106 TCID50 SHRV/mL for 5 hours and then washing the fish
induced 55% and 47% mortality, respectively (8). After initial immersion, the virus
invaded and spread throughout the fish and induced interferon production, a characteristic
of viral infection (8).
Innate Immunity
The immune system is compromised of two major branches: innate immunity and
adaptive immunity. The innate immune system provides a first line of defense against
pathogens with a immediate, non-specific response (27). In contrast, adaptive immunity
has a specific response and possesses memory. The memory of the adaptive immune
system provides a stronger response the second time a host is exposed to the pathogen
(27).
The two branches are linked in many ways and complement each other’s function
(27). Innate immunity, the focus of this study, recognizes broad classes of pathogens with
receptors that interact with proteins on the pathogen’s surface. The toll-like receptors
(TLRs) are a family of transmembrane proteins that function within the innate immune
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system as pattern recognition receptors (PRRs) (2). The PRRs are responsible for
recognizing the pathogen associated molecular patterns (PAMPs), which are ligand
motifs present on the outside of a pathogen surface. PAMPs, such as LPS and
peptidoglycan, are recognized in general by class by the PRR. The binding of PRRPAMP initiates the TLR signal transduction pathways involved in the elimination of the
pathogens, as appropriate for the general class of antigen. Activation of TLRs leads to the
activation of NF-κB and induction of cytokines and interferons (1, 45). The TLR
pathways that lead to cytokine induction have been characterized in mammals, including
humans (42); however, in lower vertebrates, such as zebrafish, the TLR signaling
pathways have not yet been defined (42, 45).
Toll-like receptors
Toll-like receptors (TLRs) were originally discovered in Drosophila as a

Figure 2: General structure of TLRs. A. Domains of general TLR. B. Phylogenetic tree of TLRs and
the PAMPs recognized. C. Differences between specific TLRs (24).
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mechanism to resist microbial infections and as an important protein in development (2,
27). An extracellular leucine-rich repeat region (LRR) and an intracellular
Toll/interleukin-1R homology (TIR) domain create the generalized TLR structure
(Figures 2, 3) (24, 27). The LRR is made up of the repeating amino acid motif
LxxLxLxxN and are characterized by a horseshoe solenoid tertiary structure (Figure 3)
and β sheets within the concave section of the horseshoe (9, 24).
TLRs can homo- and heterodimerize with
other TLR molecules (27). Intracellular
signaling takes place through adapter
molecules, such as MyD88 and TICAM,
that bind the TLR TIR domain via their
own TIR domain (24).
TLRs recognize a variety of
PAMPs, from lipoproteins to viral RNA

Figure 3: Structure of TLRs (27).

(2). TLR1, -2, -4, -5, and -6 are on the cell surface and recognize bacterial parasites,
gram-positive and gram-negative bacteria, flagellated bacteria, and fungi. Embedded in
intracellular vesicles, TLR3, -7, -8, and -9 recognize viral dsRNA and ssRNA in addition
to certain bacterial DNA elements (Figure 4) (27).

9

Figure 4: Distribution of TLRs throughout the cell and major PAMP recognized by each TLR (27).

TLRs are involved in a wide variety of cell signaling. An overview of some of the
pathways they participate in is shown in Figure 10 (44). Though all the pathways are
initiated by different signals, such as flagellin or
dsRNA, ultimately, the end is the same: apoptosis
or inflammatory and immune gene activation.
Apoptosis versus Necrosis
Cellular death is a highly controlled and
moderated process within cells. The condensing
and breakage of DNA and the creation of apoptotic
bodies characterize apoptosis, or programmed cell
Figure 5: The differences between
necrosis and apoptosis (36).

death, whereas
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necrosis is characterized by membrane blebbing and the dumping of cellular contents (17,
36). The terms associated with and utilized in cellular death are listed in Table 3 and
summarized with their major characteristics (17). Though not listed in the table, necrosis
is often associated with tissue damage. Apoptosis and necrosis can be difficult to
distinguish, especially since the same stimuli at different doses can induce both types of
cell death (15). Table 2 summarizes some of the characteristics between apoptosis and
necrosis (15). The major difference is the rupturing of the cell membrane during necrosis
that eventually leads the loss of
the cytoplasm. Inflammation is
another key difference present

Table 2: Major differences between apoptosis and necrosis (15).

in necrosis but not in apoptosis

(15).

Table 3: Terms and definitions associated with cellular death (17).

Traf2
Traf2 is a member of the Traf superfamily of proteins, all of which share certain
protein structures (5). At the carboxy-terminus, the Traf proteins share a homologous
region that is thought to mediate dimerization of the Traf molecules (5). In vivo studies of
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Traf2 and other Traf proteins such as Traf6 show oligomerizaton utilizing the common
Traf domain (7). The common Really Interesting New Gene (RING) domain is found at
the amino-terminus of the Traf proteins and functions in an unknown manner (5).
Following the RING domain, Traf proteins contain four to five zinc fingers (32). Traf
proteins are found in the cytoplasm of cells and are thus thought to be adaptor proteins
that associate with a variety of receptors, such as TNFα and CD40 (5). These receptors
often contain death domains, such as TNFR1 associated death domain (TRADD) (39).
When interacting with these death domains, Traf proteins are involved in transmitting
signals downstream, often while utilizing their E3 ubiquitin ligase activity. The signaling
cascades Traf proteins are involved in terminate in NF-κB activation and often serve as
protection from apoptosis (39).
Traf2 has been studied extensively in mice. These studies indicate that within
mice and other mammals, Traf2 exists as a single protein (54). Traf2 deficient mice are
smaller and die earlier than their control counterparts and Traf3 deficient mice (54). The
phenotype could be partially rescued with blocking of the TNF receptor (54). Shi et al
looked at Traf2 in HeLa cells and found it to undergo rapid K63 polyubiquitination
following TNF stimulation (43). This is a vital step allowing Traf2 to function as an E3
ligase with Ubc13 as the E2 ligase, often in pathways involved in regulating apoptosis
(43).
Ubiquitination
Ubiquitination is known to play a role in controlling apoptosis and cellular protein
trafficking (33). Reversible covalent modification of proteins usually takes place on Ser,
Tyr, Thr, or Lys residues. Lys and Cys are the primary targets for ubiquitination. E1

12
ligases activate the ubiquitin molecule with ATP and a thioester link. E2 ligases carry
ubiquitin to the E3 ligase for transfer to the
targeted protein through another thioester
linkage (Figure 6) (33). The major family of
E2 proteins is known as the Ubc family,
which have a catalytic core (20). The Cys
residue that carries the activated ubiquitin
can be found within the catalytic core. The

Figure 6: Action of E1, E2, and E3 ligases in
ubiquitinating a substrate (33).

absence of Cys constitutes the sub-family of
noncanonical ubiquitin-conjugating enzyme

variant (Uev). Ubc13 and Uev1 form a heterodimer. Selectivity for K63 polyubiquitin is
achieved with this unique dimer of proteins (20).
E3 ligases are a family of proteins responsible for catalyzing the addition of
ubiquitin to target proteins, primarily at K48 and K63. The ubiquitin protein has multiple
Lys residues, allowing polymerization of long chains (33). K48 polyubiquitination acts as
a signal for proteasome degradation. The long K63 linked ubiquitin tails are thought to
create a scaffold for proteins to regulate NF- B levels. Longer chains generate a more
intense signal (33).
Signaling Pathways
i. CD40 Receptor linked Activation of RelB
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In the activation of RelB, a protein in the NF- B family of transcription factors,
through the CD40 receptor, the E2 ligase Ubc13 heterodimerizes with Uev1 (33, 52). The
E2 activity of Ubc13/Uev1 is specific for tumor necrosis factor (TNF) receptorassociated factors 2 and 6 (Traf2 and Traf6) K63 polyubiquitination. Together,
Ubc13/Uev1 and Traf2/Traf6
polyubiquitination at K63 (52). Ubc13
assembles in a first tier along with the
E3 ligases Traf2 and Traf3 and cellular
inhibitors of apoptosis proteins (cIAP1 and cIAP-2) (Figure 7, box B). In
unstimulated cells, cIAP-1/cIAP-2 act

to polyubiquitinate K48 on NF-κB

Figure 7: Assembly of proteins at CD40 receptor and
translocation to the cytosol (34).

inducing kinase (NIK) in a complex
similar to the first tier of assembly in stimulated cells, but not attached to the CD40
receptor (49). Activated NIK will initiate the rest of the cascade that allows for RelB
activation and translocation to the nucleus. If stimulated, Traf2 acts to ubiqutinate cIAP1/cIAP-2 at K63, a modification which changes the K48 polyubiqutination specificity of
cIAP-1/cIAP-2. K63 polyubiqutitin cIAP-1/cIAP-2 catalyzes K48 poly-ubquitin tails to
be added to Traf3 (49). In the second step of complex assembly, the K63
polyubiqutitinated Traf2 is thought to act as a scaffold for binding of MKK4 (a substrate
for MEKK1), mitogen activated protein kinase (MAPK) protein MAP or extracellular
signal-regulated kinase kinase 1 (MEKK1), and inhibitor of nuclear factor B (I B)
kinase γ (IKKγ) (34).
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The completed protein complex is attached to the receptor though Traf3.
Proteasome degradation of Traf3, due to K48 polyubiquitin, releases the complex into the
cytosol (Figure
8). The activated
complex stops
ubiquitinating
NIK and instead
phosphorylates
NIK.
Phosphorylated

Figure 8: Noncanonical activation of NF-κB family member RelB thorugh the
CD40 receptor (49).

NIK is activated
and

phosphorylates IKKα (49). The phosphorylation of p100 occurs at S886 and S870.
Degradation and processing are signaled by K48 polyubiquitin chain catalyzed by NIK
(50). The degradation of p100 generates p52. RelB dimerizes with p52 and translocates to
the nucleus to activate transcription (49).
ii. Toll-like Receptor 3 Activation of NF-κB
TLR3 is sequestered in the endosome and will recognize dsRNA (Figure 4) (28).
Previous studies have shown it to be the only Toll-like receptor to operate independently
of the MyD88-dependent pathway (28). After a virus has successfully infected a cell, the
dsRNA is released and protein synthesis of viral proteins begins. Dimerized TLR3 can
then bind the dsRNA imported into the endosome (3, 56). Binding of antigen to the
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receptor recruits TIR domain-containing adaptor molecule 1 (TICAM1) to the
cytoplasmic end of the TLR through the TIR domain on each of the proteins (38, 53, 56).
Like other TLR adaptor proteins, TICAM1 (also known as TRIF) homodimerizes and is
capable of signaling to
activate Type 1 interferon or
NF-κB (Figure 9) (28, 38).
TICAM1 functions as a
signaling platform, allowing
a variety of proteins such as
Traf3, Traf2, Traf6, NAP1
and receptor interacting
protein 1 (RIP1) to bind and
relay signaling (3, 56).
Figure 9: Overview of pathways initiated by the TLRs (44).

Signaling through RIP1
activates NF-κB. RIP1 is auto-phosphorylated and polyubiquitinated by Peli1 or Traf2 at
K63 and K48 (49, 56). This polyubiquitin chain serves as a scaffold for the assembly of
Traf6, MAP3K, TAK1, and TAB2 (23, 56). The complex translocates to the cytoplasm
and interacts with PKR which phosphorylates TAK1 (23, 56). TAK1 activates MAP
kinase signaling cascades or activates IKK (56). The IKK complex phosphorylates IκB,
allowing NF-κB to translocate to the cytoplasm and activate pro-inflammatory cytokines
(49). RIP1 also activates caspase-8 through FADD and to promote apoptosis (56).
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iii. Toll-like Receptor 9
TLR is localized to endosomes and recognizes viral and bacterial CpG DNA
motifs found on microbial genomes (25). In unstimulated cells, TLR9 is sequestered in
the endoplasmic reticulum, but after stimulation is quickly trafficked to the endosome
and proteolytically cleaved (25). Proteolytic cleavage activates TLR9 and allows the
receptor to bind ligand (25). Like most TLRs, TLR9 has a TIR domain to recruit the
adaptor molecule myeloid differentiation factor 88 (MyD88) for signal transduction.
Binding of the TIR domain of MyD88 to the TIR domain of TLR9 initiates the MyD88dependent pathway that activates NF-κB and the MAPK signaling cascades (11, 25). The
MyD88 pathway is detailed in Figure 10.
MyD88 recruits Traf6, IRAK4, and sometimes IRAK1 and IRAK2 to assemble at
TLR9 (25). Traf6, an E3 ubiquitin ligase, activates the TAK1/TAB1/TAB2/TAB3
complex through K63 polyubiquitination, which in turn activates the classical MAPK
signaling cascade or activates NF-κB (11). In the activation of NF-κB, the TAK1/TAB
complex activates the IKK complex through phosphorylation (25). The phosphorylated
IKK complex modifies the regulatory IκB molecules with a phosphate group, targeting
IκB for destruction by the proteasome. Free NF-κB translocates into the nucleus and
induces transcription of inflammatory cytokines (25).
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Figure 5: MyD88-dependent signaling cascade to activate inflammatory cytokines (26).

iv. TNFR1 Activation of NF-κB
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Tumor necrosis factor receptor type 1 (TNFR1) is activated by the proinflammatory cytokine tumor necrosis factor α (TNFα) (29). After stimulation, the
receptor trimerizes
and recruits the
adaptor protein
TNFR1-associated
death domain
protein (TRADD)
to the cytoplasmic
domain (49).
Traf2, Traf5 and
RIP1 are all
recruited and
Figure 11: TNFR1 signaling cascade and activation of NF-κB (16).

assemble at TRADD (Figure 11) (16, 49). RIP1 is K63-linked polyubiquitinated and
Traf2 is phosphorylated by protein kinase C (PKC) (30). Phosphorylated Traf2 is K63
polyubiquitinated (30). It is thought that before phosphorylated Traf2 is
polyubiquitinated, it recruits IKKα and IKKβ (the catalytic subunits of the IKK complex)
(30). Polyubiquitination of Traf2 promotes recruitment of a TAB/transforming growth
factor-β-activated kinase 1 (TAK1) complex to the receptor complex (30). TAK1 is K63
polyubiquitinated by Traf2 (16). K63 polyubiquitinated TAK1 recruits the regulatory
protein for the IKK complex, IKKγ/NEMO by providing a scaffold for binding (16). The
completed IKK complex is then phosphorylated on the IKKβ subunit by TAK1 (16).
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Activated IKK complex phosphorylates the IκB family members, leading to IκB
degradation and release of NF-κB (49).
Genetic manipulation of the zebrafish genome
The ease of genetic manipulations in zebrafish is one of their major advantages.
Multiple techniques have been developed to knockdown or knockout genes in zebrafish.
Some of these techniques include: targeting induced local lesions in genome (TILLING),
morpholino knockdowns, and transgenesis (35).
Mopholinos have a variety of mechanisms to block protein synthesis. The general
structure of a morpholino is a twenty
five morpholino base oligomer (10).
These bind tightly and strongly to the
RNA because of their
phosphorodiamidate backbone
(Figure 12, box A) (10). The two
major forms of morpholinos are
splice blockers (Figure 12, box B)
and translational blockers (Figure 12,
Figure 12: Different modes of action for morpholinos
(10).

box E) (10). Splice blockers inhibit
the formation of the splicesome

complex and are usually used in zygotic embryos, whereas the translational blockers bind
the untranslated region of the mRNA and are used in both maternal fish and zygotic fish.
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Preliminary proceedings to discover Traf2
The ubiquity of viruses in day to day life presents many challenges in health care.
The immune system is the body’s mechanism to not only protect itself against these
invaders but to also clear infections that have taken hold. The innate immune system,
composed of generalized defense mechanisms such as skin and phagocytes, works to
clear infections during the first seven to ten days and is critical to mounting a strong
adaptive immune response. Pattern recognition receptors known as Toll-like receptors
(TLRs) are major players in recognizing the viral infection and relaying this information
into the cell.
Previous data suggest that unique signaling partners may exist in zebrafish TLR
pathways. Sullivan et al. reported several protein-protein interactions observed in the
mammalian TICAM1-dependent pathway are not observed in zebrafish (47). Yet the
zebrafish TICAM1-dependent pathway was capable of eliciting a similar cytokine profile
for Type I IFN and NF-κB activation. Due to several known mammalian protein-protein
interactions not occurring in zebrafish we hypothesized that unique protein partners must
be signaling. To identify possible
unique protein interactions a protein
pulldown assay using MyD88 as bait
was conducted. Charette et al
(unpublished) demonstrated a unique
interaction between zebrafish Traf2
and MyD88 (Figure 13).
Figure 13: Each of the three paralogs of Traf2 is
shown to associate with MyD88.

All three of the Traf2 paralogs
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interacted with MyD88, as seen in lanes 1-3. The purpose of this study was to look at the
potential roles for Traf2 in zebrafish signaling, particularly during a viral infection.
Materials and Methods
Zebrafish maintenance
Zebrafish embryos of the wild-type AB strain were maintained in petri dishes
containing no more than two hundred embryos in 60 mL of egg water (60 mg/L Instant
Ocean, Spectrum Brands, Madison, WI). For 6 h post fertilization, egg water was
supplemented with 20 μL 0.1% methylene blue to help prevent fungal growth and
bacterial infections. After immersion in methylene blue, embryos were split into plates
containing two hundred embryos. Embryos were maintained in a 28 oC incubator and egg
water was changed daily. Maintenance was modified from Phelan et al (40).
Morpholino knockdown
Morpholino injections were performed according to Bill et al with some
modifications (10). Antisense morpholino oligonucleotides (MO) were designed by
GeneTools (Philomath, OR) for each paralog of Traf2 to block splicing (Table 4). Within
1 hpf, embryos yolks were injected with 2 nL MO of each of the appropriate morpholinos
using an MPPI-2 pressure injection system (Applied Scientific Instrumentation, Eugene,
OR). After injection, embryos were immersed in 20 μL 0.1% methylene blue in 60 mL
egg water for 5 h.
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Table 4: Morpholinos used in this experiment.

Name

Sequence

MW

TNFR1v1
constant
34
TNFR1v2
constant
33
Traf2a1
E1/I1
Traf2A2
E1/I1
Traf2b
E1/I1

TACGTCCTTGTGCATTGCTGGCATC

Mol. Weight OD
Abs.
8417 249090 2.53
74.73

CTGCATTGTGACTTACTTATCGCAC

8385 254250 2.52

76.27

CAGGACTGAATGCCGCTTACCTCAC

8389 255430 2.52

16.63

AGATCAGCGGTGTGAATTACCCAAC 8477 264190 2.54

79.26

TTTAAGAATCAAGGCTTACCACTGC

79.11

8427 263690 2.53

Immersion infections
At 3 dpf, one hundred embryos per treatment of morpholino knockdowns (the
triple knockdown of all three Traf2 genes, control morpholino) added to small petri
dishes. A concentration of 1 x 106 TCID50 SHRV per mL-1 was added to the fish. After
incubation for 5 h, the embryos were washed 3 times in 60 mL of clean egg water. On a
daily basis for 5 days, egg water was changed and zebrafish were monitored for
mortalities. This procedure was modified from Phelan et al (40).
Viral burden studies
Ten fish were collected and homogenized in media every 24 h. Viral burden was
determined by serially diluting the filtered homogenate in EPC cells (40). After 48 h cells
were examined for death. This procedure was adapted from Phelan et al (40).
TUNEL Assay
Ten fish were collected for each TUNEL timepoint and incubated overnight at 4
o

C in 500 μL of 4% para-formaldehyde (PFA) in a 1.5 mL microcentrifuge tube. Fish
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were immersed once for 5 min in 33% MeOH in PBS and 66% MeOH in PBS, and
immersed twice in 100% MeOH for 5 min. The permeablized fish were then stored at
−20oC. This procedure was adapted from Yabu et al (51).
The TUNEL assay itself was adapted from Invitrogen (21). Individual fish were
transferred to 1.5 mL microcentrifuge tubes and treated with 5-min washes in 66%
MeOH in PBS, and 33% MeOH in PBS, followed by 2 5-min washes in (51). Fish were
equilibrated in TdT buffer for 10 min (21). After 2 h at 37oC in the TdT reaction cocktail
(21), the fish were washed twice for 20 min in 1x Western Blocking buffer in TBS
(Roche 1921673 Brandford, CT) (12, 21). Finally, fish were treated for 30 min at room
temperature in the dark with Click-iT reaction cocktail (Invitrogen) before an overnight
incubation at 4 oC in 1x Western Blocking buffer in TBS (21).
Ubiquitin Assay
293T cells at 90 – 95% confluency were transfected with one of the Traf2
paralogs tagged with hemagluttin (HA), RIP1 tagged with myc, and wild type ubiquitin
plasmid tagged with HA using Lipofectamine 2000 according to the manufacturer’s
recommendations (Addgene #17608). At 6 h post transfection (hpt), media was replaced
with 100 nM sphingosine 1-phosphate. At 48 hpt, the cells were washed with phosphate
buffered solution(PBS) (Invitrogen Life Technologies) and lysed in buffer containing 50
mM Tris-HCl at a pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and a protease
inhibitor (Sigma-Aldrich) (48). After centrifugation at 16,000 x g for 15 min, the cleared
cell lysate was incubated overnight at 4 oC with anti-HA agarose affinity gel resin or antimyc agarose affinity gel resin (Sigma-Aldrich, St. Louis, MO). The whole cell lysate and
immunoprecipitate were washed 3 times in buffer containing 25 mM Tris-HCl (pH 7.2),
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150 mM NaCl, and 0.05% Tween 20 (48). The immunoprecipitates were eluted in 2x
lane marker nonreducing sample buffer for 5 min at 100 oC (Pierce Rockford, IL) and
separated on a SDS-PAGE gel (48). The separated proteins were transferred onto
nitrocellulose overnight at 4 oC. Membranes were blocked with TBS (pH 7.5) with 0.1%
Tween 20 and 5% nonfat dried milk before treating with mouse monoclonal primary
antibody against the myc tag at 1:500 for 2 h at room temperature (Santa Cruz
Biotechnology) and a secondary anti-mouse antibody linked to HRP for imaging at
1:50,000 overnight at 4 oC (Amersham Biosciences). Polyclonal rabbit anti-HA, at 1:250
was incubated for 2 h at room temperature for the other immunoprecipitate (Thermo
Scientific) and the secondary goat anti-rabbit monoclonal IgG linked to horse radish
peroxidase (HRP) for imaging at 1:50,000 was incubated overnight at 4 oC (Santa Cruz
Biotechnology). This procedure was adapted from Sullivan et al (48).
Confocal microscopy
Images were analyzed with an Olympus IX-81 equipped with an Olympus FV1000 laser scanning confocal unit using the Olympus FV-10 software package.

25
Results
Traf2 knockdown fish exhibit greater mortality when infected with SHRV.

Figure 14: Triple knockdown Traf2 fish experience greater mortality than control fish when infected
with SHRV. Mean mortality in Traf2 triple knockdown fish challenged with SHRV as compared to control
infected fish and uninfected fish. Error bars represent the standard error between the two replicates.

Previous studies done by Yeh et al showed early lethality in Traf2 deficient mice
and runting in the mice (54). We investigated whether zebrafish embryos showed the
same runting and premature death. Zebrafish embryos were injected with the three Traf2
morpholinos at once (Table 4) at the one to two cell stages. At 3 dpf the embryos were
immersed in 1 x 106 TCID50/ml SHRV for 6 h. Survival was monitored over the next 5
days. Higher levels of mortalities were observed in Traf2 triple knockdown challenenged
with SHRV compared to control zebrafish (Figure 14). These results indicated the during
a virus infection of the zebrafish, knockdown of the three Traf2 paralogs leads to greater
mortality.
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Figure 15: Pairwise knockdown Traf2 fish experience greater levels of mortality when infected with
SHRV than control fish. Mean mortality levels in Traf2 pairwise knockdown fish after SHRV challenge.
Error bars represent the standard error between the two replicates.
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We wanted to investigate whether the increased mortality seen in Traf2 trimorphants was due to the combined action of all three paralogs or if two served
redundant and protective roles. To investigate this question, we knocked down all three
pairs of Traf2 morpholinos and the individual Traf2 morpholinos (Table 3). The pairwise
knockdowns of the Traf2 paralogs showed an increase in mortality over the control
zebrafish as well (Figure 15). However, the single knockdowns of Traf2 paralogs did not
show an increase in mortality compared to the control zebrafish (Figure 16).
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Figure 16: Knockdown of the individual Traf2 genes in fish infected with SHRV does not increase
mortality as compared to control fish. Mean mortality of individual Traf2 knockdown fish challenged
with SHRV as compared to control fish. Error bars represent standard error between two replicates.

The results indicate that Traf2 pairwise morphants are more susceptible to death during a
viral infection, but that individual Traf2 genes are not sufficient to cause this increase in
mortality during viral infection.
Traf2 zebrafish and control fish have no difference in viral burden
An increase in mortality during a viral infection is often the result of a high viral
burden. To determine if this was the case in our scenario, the fish were sampled for viral
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burden every 24 h for 3 days.

Figure 17: Traf2 tri-morphants do not have a greater viral burden than control fish. Mean viral
burden in SHRV challenged tri-morphant Traf2 zebrafish.

There was no significant difference in viral burden between the triple Traf2 knockdown
fish and the control fish (Figure 17). This indicates that although Traf2 morphants exhibit
a higher mortality during viral infection, the increase in mortality is not due to an
increaed amount of virus infecting the fish.
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TNFR1 knockdown does not improve mortality seen with Traf2 knockdowns
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Figure 18: Eliminating the receptor TNFR1 does not increase survival in Traf2 triple knockdown
fish. Mean mortality of Traf2/TNFR1 morphants as compared to controls. Error bars represent standard
error between two replicates.

To determine the possible pathways that Traf2 is involved in, the TNFR1 receptor
was knocked down alone or with the three Traf2 paralogs. It has been shown that Traf2
has a protective role in the TNFR1 pathway (37). By removing the receptor, there was an
increase in survival of the mice in the study done by Nguyen et al (37). Few fish survived
until the third day for infection with SHRV, so the fish mortality while uninfected was
monitored from 24 hpf on until 120 hpf. We did not, however, see an increase in survival
when we knockdown Traf2 with TNFR1 (Figure 18). Bates et al were able to use the
TNFR1 morpholinos with success in their own experiments, though they were not using
the morpholinos in conjugation with the Traf2 morpholinos (6). Thus the lack of rescue
in the zebrafish when using the TNFR1/Traf2 tri-morphants may be because the zebrafish
Traf2 proteins are not as intimately involved in the TNFR1 signaling pathway as mouse
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Traf2 is in the mouse TNFR1 pathway. The results from this experiment do not show an
increase in survival in Traf2 tri-morphants that are also deficient in TNFR1.
Traf2 may increase apoptosis, which may lead to increased mortality
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Figure 19: Triple knockdown Traf2 fish infected with SHRV experience greater levels of apoptosis
than control infected fish. Mean number of cells undergoing apoptosis in Traf2 tri-morphants challenged
with SHRV. Error bars represent standard error between the three fish sampled.

Previous studies have indicated that Traf2 negatively regulates apoptosis through
the Caspase-8 pathway (19). To look at the possible role of Traf2 in preventing apoptosis
in the zebrafish, we analyzed SHRV infected fish at 1 – 4 dpi via the TUNEL assay. The
TUNEL assay attaches a fluorescent probe to the nicked ends of DNA. A characteristic
feature of cells undergoing apoptosis is DNA fragmentation, a process that leaves lots of
ends of DNA open for TUNEL staining (36). TUNEL stained fish were analyzed by
confocal microscopy. Cells undergoing apoptosis were counted in each fish, though
results were inconsistent. In general there were more apoptosic cells in the Traf2
knockdown fish than in the controls, however the difference in number of apoptotic cells
was not statistically significant (Figure 19).
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Traf2 as E3 ubiquitin ligase
In mammalian systems, Traf2 acts as an E3 ubiquitin ligase, ubiquitinating cIAP1/cIAP-2 at K63 (49). To investigate whether the three Traf2 paralogs in zebrafish could
function as an E3 ubiquitin ligase, 293T cells were transfected with plasmids containing
the Traf2 paralogs, RIP1, and ubiquitin, (Figures 20 – 22) (31). The cells were lysed and
immunoprecipitated for the myc tag. This targests RIP1, a potential target for E3
ubiquitination by Traf2. A second experiment immunoprecipitated for the HA tag,
targeting the ubiquitin molecules and the Traf2 paralogs. Traf2a2 is expressed by the
transfected 293T cells, but the other two Traf2 paralogs are not. This may be due to poor
expression of Traf2a1 and 2b and is a problem we are actively still investigating. Traf2a1
and 2b could also be masked by high expression of ubiquitin. RIP1 expression was also
observed in expressed transfected 293T cells (Figure 21). RIP1 did not produce smearing
that is characteristic of polyubiquitinated proteins (Figure 20), leading us to believe that
polyubiquitination is not occurring between the individual Traf2 paralogs and RIP1. RIP1
is not being ubiquitinated in these cells as the immunoprecipitate for HA blotted for the
myc tag yielded no product.
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Figure 20: RIP1 is not ubiquitinated by Traf2. Immunoblot of cell lysate immunoprecipitated for the
myc tag present on RIP1. The top box was blotted for the HA tag present on the Traf2 proteins and
ubiquitin, while the bottom box was blotted for the myc tag.
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Figure 21: Ubiquitin is most likely present in the cells. The top box is an immunoblot of cell lysate
immunoprecipitated for the HA tag present on ubiquitin and the Traf2 proteins and blotted for the HA tag
present on the Traf2 proteins and ubiquitin. The bottom box was blotted the whole cell lysate blotted for the
myc tag.
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Figure 22: Traf2a2 is the only Traf2 paralog to be expressed in the blot. Immunoblot of the whole cell
lysate for the HA tag present on ubiquitin and the Traf2 proteins.
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Discussion
Traf2 is critical in regulating apoptosis in mammalian systems. It acts as an E3
ligase to poly-ubiquitinate cIAP-1/cIAP-2 at K63 (34, 49). In mice, Traf2 deficiency
caused runting and early death due either to TNF receptor lethality or increased apoptosis
(54). In mammalian systems, Traf2 exists as a single protein involved in a variety of
pathways, including TLR3, TNFR1, and many others with death domains (39). Zebrafish
are unique and possess three Traf2 paralogs: Traf2a1, Traf2a2, and Traf2b. The potential
for unique interactions with other proteins like MyD88 (Figure 13) makes research with
the zebrafish Traf2 proteins vital to understanding the alternative pathways and
mechanisms organisms use to protect against inflammation and apoptosis.
Previous studies using mice as a model demonstrated that Traf2 deficiency leads
to early mortality without infection (54). If zebrafish experience lethality in the same
manner as mammalian
systems, it will provide
insight into the pathways
that utilize the zebrafish
Traf2 paralogs. The
Traf2 tri-morphants
infected with SHRV
experiences greater

Figure 23: TNFα signaling pathway to inflammatory cytokines or
apoptosis (19).

levels of mortality than
the control fish (Figure

14). This may be due to Traf2 involvement in anti-apoptotic pathways, perhaps acting as
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mlevels of mortality in fish prior to infection that were between 24 and 72 hpf were
observed (Figure 18). In Figure 24 we can see that Traf2 works to inhibit apoptosis
through the Caspase-8 pathway. By removing Traf2, there is potential for greater
apoptosis without that level of regulation. Apoptosis will occur because Traf2, which is a
negative regulator of the Caspase-8-dependent pathway, has been removed, allowing the
pathway to proceed. Greater levels of apoptosis could cause an increase in mortality.
Mice deficient in Traf2 showed early lethality and runting, similar to the effects seen in
the zebrafish (54). Yeh et al determined that this early mortality was not just due to Traf2
playing a role in TNFR signaling, but that Traf2 must also be vital in other signaling
pathways such as TLR3 signaling and signaling through the CD40 receptor (54). These
findings are consistent with our findings in the zebrafish. The pairwise knockdown fish
experience similar levels of mortality rates to each other, from 50 – 70 % survival (Figure
15), suggesting that at least two of the paralogs of Traf2 are required for function. When
paired with the results of the single Traf2 morphants where no increase in mortality is
observed (Figure 16), this suggests that zebrafish Traf2 may be forming heterodimers or
even heterotrimers, a result consistent with previous studies have shown demonstrating
that mammalian Traf2 homodimerize (43).
The increase in mortality observed in virus infected Traf2 morphants may be due
to the inability to clear the virus. The viral burden was assessed in both Traf2 trimorphants and control fish and there was no significant difference in viral burden (Figure
17). Therefore, the increase in mortality is not due to an increase in viral burden. Traf2 is
not a key player in a pathway that clears virus.
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Since viral burden is not the cause of the increase in mortality, we looked at the
levels of apoptosis in the fish. In mammals, Traf2 is a negative regulator of apoptosis in
Caspase-8 pathway (Figure 23). Utilizing the TUNEL assay to label apoptotic cells in
vivo, SHRV infected Traf2 tri-morphants and control fish were compared over 4 days. A
moderate increase in apoptotic cells in the Traf2 tri-morphants was observed (Figure 18),
though these numbers varied widely between replicates. The greatest increase in
apoptosis occurs between two and three days post infection. The apoptosis seen in the
fish was localized mostly along the fin of the tail and could be due to developmental
apoptosis or normal cell death on the skin edge. The Traf2 tri-morphants did have some
apoptosis in the eye region; this was not significantly different than the control fish. The
slight increase in apoptosis in the Traf2 tri-morphants could also be caused by off-target
effects of morpholinos, as not all morpholinos have the same effects on the developing
embryos (10). It is entirely possible that the Traf2 morpholinos have the potential to
cause more p53-induced apoptosis than the control morpholinos, particularly since we
saw apoptosis in the eye region, which is characteristic of the off target effects (10).
Reimers et al used the TUNEL assay in conjugation with an acridine orange stain to
depict apoptosis in ethanol stressed zebrafish embryos (41). Acridine orange stains cells
undergoing death in general, and does not allow differentiation between necrosis and
apoptosis. For this reason, we chose to only use the TUNEL assay, which is specific for
apoptosis through the tagging of nicked DNA. Reimers et al were able to show apoptosis
in embryos of a similar age range, in much greater quantities than we were able to
achieve (41). Reimers’ group may have been more successful in their numbers because
they were not co-injecting with the Traf2 morpholinos or because they did not need as
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great of numbers of zebrafish embryos to survive. For infection/mortality studies, we
need a greater number of fish to survive until the third day post fertilization than for
studies focusing just on mortality. Because results were inconsistent, we cannot
definitively say that the increase in mortality is caused by the Traf2 knockdown, but it
may be a contributing factor.
Because simultaneous removal of the TNFR1 receptor with Traf2 rescues the
effects in Traf2 deficient mice, the TNFR1 receptor was knocked down in the zebrafish
(54). However, there was not a significant increase in survival of the Traf2 tri-morphants.
In zebrafish, unlike mice, there are two TNFR1 receptor genes: TNFR1v1 and TNFR1v2.
The TNFR1 morpholinos were originally described by Bates et al in zebrafish (6). The
group showed TNFR1 deficient fish were more resistant to lipopolysaccharide exposure,
a potent toxin (6). Simultaneous knockdown of TNFR1v1, TNFR1v2, Traf2a1, Traf2a2,
and Traf2b resulted in no change in mortality as compared to the Traf2 tri-morphants
(Figure 18). Knockdown of TNFR1v1 and TNFR1v2 may have rescued the Traf2 trimorphant high mortality phenotype but the high amount of morpholino that was injected
per embryo may have caused off-target effects. Morpholinos have the potential to cause
side effects such as enlarged eyes, swollen yolk sacks and early death (10). The lack of
rescue in our studies may be because of a difference in the TNFR1 pathways of mice and
zebrafish. Though Traf2 is involved in the mouse TNFR1 pathway, the zebrafish may use
an alternative method of signaling. Incomplete rescue of the Traf2 tri-morphants may
also be due to cross-talk amongst different pathways. For instance, in mammalian
systems both TLR3 and TNFR1 utilize RIP1 in downstream cascades (13). RIP1 is
polyubiquitinated and eventually leads to NF-κB activation in both the TLR3 pathway
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stimulated by dsRNA and the TNFR1 pathways stimulated by TNFα (13). Using just
TNFR1v1 knockdown simultaneously with the Traf2 tri-morphants did not rescue the
mortality. There were still off-target morpholino effects, which could be because of the
effects of the other TNFR1 gene still present.
In mammalian systems, Traf2 has been shown to function as an E3 ligase that
K63 poly-ubiquitinates cIAP-1/cIAP-2 and other proteins (34, 49). We looked at the
potential for each of the three Traf2 paralogs to play a similar role with RIP1. Previous
studies have shown that mammalian Traf2 function as an E3 ligase with Ubc13-Uev1a as
the E2 ligase to polyubiquitinate RIP1 at K63 on RIP1 (4). When RIP1 is
polyubiquitinated the tail of ubiquitin acts as a scaffold for other signaling molecules and
complex formation (16). Alvarez et al found that sphingosine-1-phosphate is necessary
for this reaction to take place (4). In our own transfection, we did used sphingosine-1phosphate and RIP1 as our potential target for ubiquitination. We did not however, see
ubiquitination of RIP1 (Figures 20, 21). Traf2a2 and RIP1 were strongly expressed in the
cells (Figures 20, 22). The other proteins may not have been expressed in the cells. To
determine if Traf2a1 and Traf2b are viable for expression in the cells, sequencing would
need to be done. In Figure 22 we do see the characteristic smearing of ubiquitin, but
because both ubiquitin and Traf2 have the same HA tag we cannot definitively say
Traf2a1, Traf2a2, and Traf2b are being masked by ubiquitination of something else in the
cell. The three Traf2 paralogs were transfected separately and this could be part of the
reason ubiquitination did not occur. Previous studies show that Traf2 oligomerizes with
itself and other members of the Traf superfamily utilizing the Traf domain (7). Perhaps
the existence of three Traf2 proteins in zebrafish means that for fully functional ability at
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least two of the paralogs must be present to complex together, or for all three even to be
necessary. Based on our own mortality studies earlier, where we saw a decrease in
survival when two or more Traf2 paralogs were knocked down as opposed to the single
Traf2 paralog morphants whose survival was not significantly different than control fish,
it could be surmised that just two are necessary. With what we have seen so far, it is
inconclusive whether the Traf2 paralogs are acting as E3 ubiquitin ligases for RIP1.
Further experiments are necessary to determine if the zebrafish Traf2 paralogs act
as ubiquitin ligases. In particular, I would try a transfection with all three paralogs in one
set of cells with RIP1. Other transfections with potential targets for ubiquitination such as
TAK1 would show if Traf2 in zebrafish is just targeting something else. The conditions
of the transfection could also be modified. For instance, it would be beneficial to change
the HA tag on ubiquitin to something else. With the current tag, our immunoprecipitate
for HA may have become too saturated with ubiquitinated molecules to hold any of the
Traf2 proteins. It would also be interesting to try another rescue of the phenotype seen in
the Traf2 tri-morphants. This might be achieved by knocking down a different potential
receptor, such as TLR 3 or TLR 9 and infecting the fish. Part of our difficulties in the
experiments has been getting the fish to survive long enough to have a sufficient number
for experiments at an older age. Co-injecting with the p53 morpholino as suggested by
Bill et al could help to eliminate some of these off target effects (10).
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